FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128759079> ?p ?o ?g. }

• W2128759079 endingPage "E765" @default.
• W2128759079 startingPage "E754" @default.
• W2128759079 abstract "Telomerase promoter mutations (TERT) were recently described in follicular cell-derived thyroid carcinomas (FCDTC) and seem to be more prevalent in aggressive cancers. We aimed to evaluate the frequency of TERT promoter mutations in thyroid lesions and to investigate the prognostic significance of such mutations in a large cohort of patients with differentiated thyroid carcinomas (DTCs). This was a retrospective observational study. We studied 647 tumors and tumor-like lesions. A total of 469 patients with FCDTC treated and followed in five university hospitals were included. Mean follow-up (±SD) was 7.8 ± 5.8 years. Predictive value of TERT promoter mutations for distant metastasization, disease persistence at the end of follow-up, and disease-specific mortality. TERT promoter mutations were found in 7.5% of papillary carcinomas (PTCs), 17.1% of follicular carcinomas, 29.0% of poorly differentiated carcinomas, and 33.3% of anaplastic thyroid carcinomas. Patients with TERT-mutated tumors were older (P < .001) and had larger tumors (P = .002). In DTCs, TERT promoter mutations were significantly associated with distant metastases (P < .001) and higher stage (P < .001). Patients with DTC harboring TERT promoter mutations were submitted to more radioiodine treatments (P = .009) with higher cumulative dose (P = .004) and to more treatment modalities (P = .001). At the end of follow-up, patients with TERT-mutated DTCs were more prone to have persistent disease (P = .001). TERT promoter mutations were significantly associated with disease-specific mortality [in the whole FCDTC (P < .001)] in DTCs (P < .001), PTCs (P = .001), and follicular carcinomas (P < .001). After adjusting for age at diagnosis and gender, the hazard ratio was 10.35 (95% confidence interval 2.01–53.24; P = .005) in DTC and 23.81 (95% confidence interval 1.36–415.76; P = .03) in PTCs. TERT promoter mutations are an indicator of clinically aggressive tumors, being correlated with worse outcome and disease-specific mortality in DTC. TERT promoter mutations have an independent prognostic value in DTC and, notably, in PTC." @default.
• W2128759079 created "2016-06-24" @default.
• W2128759079 creator A5005703946 @default.
• W2128759079 creator A5011822857 @default.
• W2128759079 creator A5011908578 @default.
• W2128759079 creator A5015493702 @default.
• W2128759079 creator A5017997346 @default.
• W2128759079 creator A5022698010 @default.
• W2128759079 creator A5026159031 @default.
• W2128759079 creator A5026672125 @default.
• W2128759079 creator A5033846370 @default.
• W2128759079 creator A5036146928 @default.
• W2128759079 creator A5041036500 @default.
• W2128759079 creator A5042372238 @default.
• W2128759079 creator A5050266625 @default.
• W2128759079 creator A5058199857 @default.
• W2128759079 creator A5059760527 @default.
• W2128759079 creator A5063696842 @default.
• W2128759079 creator A5064704033 @default.
• W2128759079 creator A5065364190 @default.
• W2128759079 creator A5067808731 @default.
• W2128759079 creator A5070785456 @default.
• W2128759079 creator A5078573061 @default.
• W2128759079 creator A5083023793 @default.
• W2128759079 creator A5089587268 @default.
• W2128759079 creator A5090041703 @default.
• W2128759079 creator A5024887069 @default.
• W2128759079 date "2014-05-01" @default.
• W2128759079 modified "2023-10-15" @default.
• W2128759079 title "TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas" @default.
• W2128759079 cites W1600373583 @default.
• W2128759079 cites W1981975876 @default.
• W2128759079 cites W1982804549 @default.
• W2128759079 cites W1990196512 @default.
• W2128759079 cites W1999324180 @default.
• W2128759079 cites W2000941161 @default.
• W2128759079 cites W2000971601 @default.
• W2128759079 cites W2013073993 @default.
• W2128759079 cites W2030209169 @default.
• W2128759079 cites W2030976397 @default.
• W2128759079 cites W2031978342 @default.
• W2128759079 cites W2034269086 @default.
• W2128759079 cites W2034818124 @default.
• W2128759079 cites W2036817519 @default.
• W2128759079 cites W2039059303 @default.
• W2128759079 cites W2041824664 @default.
• W2128759079 cites W2045177986 @default.
• W2128759079 cites W2062493935 @default.
• W2128759079 cites W2062836415 @default.
• W2128759079 cites W2067521148 @default.
• W2128759079 cites W2087799160 @default.
• W2128759079 cites W2098760638 @default.
• W2128759079 cites W2100139835 @default.
• W2128759079 cites W2100378386 @default.
• W2128759079 cites W2100669371 @default.
• W2128759079 cites W2103523670 @default.
• W2128759079 cites W2104500293 @default.
• W2128759079 cites W2107717011 @default.
• W2128759079 cites W2112027306 @default.
• W2128759079 cites W2128118436 @default.
• W2128759079 cites W2131117209 @default.
• W2128759079 cites W2133539484 @default.
• W2128759079 cites W2168631000 @default.
• W2128759079 cites W2170798594 @default.
• W2128759079 cites W2320635188 @default.
• W2128759079 cites W4367435844 @default.
• W2128759079 doi "https://doi.org/10.1210/jc.2013-3734" @default.
• W2128759079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4191548" @default.
• W2128759079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24476079" @default.
• W2128759079 hasPublicationYear "2014" @default.
• W2128759079 type Work @default.
• W2128759079 sameAs 2128759079 @default.
• W2128759079 citedByCount "427" @default.
• W2128759079 countsByYear W21287590792014 @default.
• W2128759079 countsByYear W21287590792015 @default.
• W2128759079 countsByYear W21287590792016 @default.
• W2128759079 countsByYear W21287590792017 @default.
• W2128759079 countsByYear W21287590792018 @default.
• W2128759079 countsByYear W21287590792019 @default.
• W2128759079 countsByYear W21287590792020 @default.
• W2128759079 countsByYear W21287590792021 @default.
• W2128759079 countsByYear W21287590792022 @default.
• W2128759079 countsByYear W21287590792023 @default.
• W2128759079 crossrefType "journal-article" @default.
• W2128759079 hasAuthorship W2128759079A5005703946 @default.
• W2128759079 hasAuthorship W2128759079A5011822857 @default.
• W2128759079 hasAuthorship W2128759079A5011908578 @default.
• W2128759079 hasAuthorship W2128759079A5015493702 @default.
• W2128759079 hasAuthorship W2128759079A5017997346 @default.
• W2128759079 hasAuthorship W2128759079A5022698010 @default.
• W2128759079 hasAuthorship W2128759079A5024887069 @default.
• W2128759079 hasAuthorship W2128759079A5026159031 @default.
• W2128759079 hasAuthorship W2128759079A5026672125 @default.
• W2128759079 hasAuthorship W2128759079A5033846370 @default.
• W2128759079 hasAuthorship W2128759079A5036146928 @default.
• W2128759079 hasAuthorship W2128759079A5041036500 @default.
• W2128759079 hasAuthorship W2128759079A5042372238 @default.
• W2128759079 hasAuthorship W2128759079A5050266625 @default.

• next